The Food and Drugs Authority (FDA) has cautioned the public against falsified “Dr. Alfred Capsules” circulating on social media after laboratory tests detected undeclared sildenafil citrate in the products.
The FDA, in a notice issued on September 9, 2026, said the falsified capsules are being marketed as a dietary supplement for male vitality but have not been registered by the Authority.
The Authority said its investigations uncovered an organised operation allegedly manufacturing and distributing the products in Accra, Suhum and other parts of the country. Two suspects are currently on police enquiry bail and assisting with investigations.
The FDA said the products are manufactured in “unauthorised, unregulated and unhygienic environments” and “pose a critical public health risk to the public.”
Laboratory tests conducted by the FDA’s Centre for Laboratory Services and Research confirmed the presence of sildenafil citrate.
“Sildenafil Citrate is a Phosphodiesterase Type 5 (PDE5) inhibitor, which is an undeclared drug substance in the falsified product.”
The FDA explained that sildenafil citrate is a prescription-only medicine used to treat erectile dysfunction in men and pulmonary arterial hypertension.
The Authority has urged consumers to avoid the falsified Dr. Alfred Capsules and exercise caution when purchasing male-enhancement products, particularly those advertised or sold through social media.
